Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Future Oncology (London, England)
|
December 15, 2010
TNF: a tumor-suppressing factor or a tumor-promoting factor?
Fran Balkwill, Christian Joffroy
Anticancer Research
|
June 11, 2013
Antiestrogens suppress effects of transforming growth factor-β in breast cancer cells via the signaling axis estrogen receptor-α and Y-box Binding Protein-1
Simone L Popp, Christian Joffroy, Matthias B Stope, et al.
FEMS Yeast Research
|
October 18, 2006
An in vitro assay to study the transcriptional response during adherence of Candida albicans to different human epithelia
Kai Sohn, Ilknur Senyürek, Jasmin Fertey, et al.
Anticancer Research
|
December 1, 2017
Y-box Binding Protein-1 Enhances Oncogenic Transforming Growth Factor β Signaling in Breast Cancer Cells <i>via</i> Triggering Phospho-Activation of Smad2
Matthias B Stope, Martin Weiss, Dominique Koensgen, et al.
Molecular Cancer Therapeutics
|
September 5, 2013
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity
Shane A Olwill, Christian Joffroy, Hendrik Gille, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Future Oncology (London, England)
|
December 15, 2010
TNF: a tumor-suppressing factor or a tumor-promoting factor?
Fran Balkwill, Christian Joffroy
Anticancer Research
|
June 11, 2013
Antiestrogens suppress effects of transforming growth factor-β in breast cancer cells via the signaling axis estrogen receptor-α and Y-box Binding Protein-1
Simone L Popp, Christian Joffroy, Matthias B Stope, et al.
FEMS Yeast Research
|
October 18, 2006
An in vitro assay to study the transcriptional response during adherence of Candida albicans to different human epithelia
Kai Sohn, Ilknur Senyürek, Jasmin Fertey, et al.
Anticancer Research
|
December 1, 2017
Y-box Binding Protein-1 Enhances Oncogenic Transforming Growth Factor β Signaling in Breast Cancer Cells <i>via</i> Triggering Phospho-Activation of Smad2
Matthias B Stope, Martin Weiss, Dominique Koensgen, et al.
Molecular Cancer Therapeutics
|
September 5, 2013
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity
Shane A Olwill, Christian Joffroy, Hendrik Gille, et al.
Page
of 1